Open AccessSTROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease
Author(s) -
Sachdev Perminder S.,
Lo Jessica W.,
Crawford John D.,
Mellon Lisa,
Hickey Anne,
Williams David,
Bordet Régis,
Mendyk AnneMarie,
Gelé Patrick,
Deplanque Dominique,
Bae HeeJoon,
Lim JaeSung,
Brodtmann Amy,
Werden Emilio,
Cumming Toby,
Köhler Sebastian,
Verhey Frans R.J.,
Dong YanHong,
Tan Hui Hui,
Chen Christopher,
Xin Xu,
Kalaria Raj N.,
Allan Louise M.,
Akinyemi Rufus O.,
Ogunniyi Adesola,
KlimkowiczMrowiec Aleksandra,
Dichgans Martin,
Wollenweber Frank A.,
Zietemann Vera,
Hoffmann Michael,
Desmond David W.,
Linden Thomas,
Blomstrand Christian,
Fagerberg Björn,
Skoog Ingmar,
Godefroy Olivier,
Barbay Mélanie,
Roussel Martine,
Lee ByungChul,
Yu KyungHo,
Wardlaw Joanna,
Makin Stephen J.,
Doubal Fergus N.,
Chappell Francesca M.,
Srikanth Velandai K.,
Thrift Amanda G.,
Donnan Geoffrey A.,
Kandiah Nagaendran,
Chander Russell J.,
Lin Xuling,
Cordonnier Charlotte,
Moulin Solene,
Rossi Costanza,
Sabayan Behnam,
Stott David J.,
Jukema J. Wouter,
Melkas Susanna,
Jokinen Hanna,
Erkinjuntti Timo,
Mok Vincent C.T.,
Wong Adrian,
Lam Bonnie Y.K.,
Leys Didier,
Hé Hilde,
Bombois Stéphanie,
Lipnicki Darren M.,
Kochan Nicole A.
Publication year - 2016
Publication title -
alzheimer's and dementia: diagnosis, assessment and disease monitoring
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.497
H-Index - 37
ISSN - 2352-8729
DOI - 10.1016/j.dadm.2016.10.006
Subject(s) - neurocognitive , cognition , stroke (engine) , dementia , medicine , vascular dementia , disease , cognitive decline , epidemiology , cohort , gerontology , psychiatry , pathology , mechanical engineering , engineering
The Stroke and Cognition consortium (STROKOG) aims to facilitate a better understanding of the determinants of vascular contributions to cognitive disorders and help improve the diagnosis and treatment of vascular cognitive disorders (VCD). Methods Longitudinal studies with ≥75 participants who had suffered or were at risk of stroke or TIA and which evaluated cognitive function were invited to join STROKOG. The consortium will facilitate projects investigating rates and patterns of cognitive decline, risk factors for VCD, and biomarkers of vascular dementia. Results Currently, STROKOG includes 25 (21 published) studies, with 12,092 participants from five continents. The duration of follow‐up ranges from 3 months to 21 years. Discussion Although data harmonization will be a key challenge, STROKOG is in a unique position to reuse and combine international cohort data and fully explore patient level characteristics and outcomes. STROKOG could potentially transform our understanding of VCD and have a worldwide impact on promoting better vascular cognitive outcomes.